European Journal of Surgical Oncology
Volume 36, Issue 6 , Pages 568-574 , June 2010

Utility or futility of prognostic scoring systems for colorectal liver metastases in an era of advanced multimodal therapy

  • E. Gregoire

      Affiliations

    • AP-HP Hôpital Paul Brousse, Centre Hépato-Biliaire, 12-14 Avenue Paul Vaillant Couturier, F-94804 Villejuif, France
    • ,
  • E. Hoti

      Affiliations

    • AP-HP Hôpital Paul Brousse, Centre Hépato-Biliaire, 12-14 Avenue Paul Vaillant Couturier, F-94804 Villejuif, France
    • Liver Transplant Unit, Saint Vincent University Hospital, Elm Park, Dublin 4, Ireland
    • ,
  • D.L. Gorden

      Affiliations

    • AP-HP Hôpital Paul Brousse, Centre Hépato-Biliaire, 12-14 Avenue Paul Vaillant Couturier, F-94804 Villejuif, France
    • Division of Hepatobiliary Surgery and Liver Transplantation, Vanderbitt University Medical Center, Nashville, TN, USA
    • ,
  • S. de la Serna

      Affiliations

    • AP-HP Hôpital Paul Brousse, Centre Hépato-Biliaire, 12-14 Avenue Paul Vaillant Couturier, F-94804 Villejuif, France
    • ,
  • G. Pascal

      Affiliations

    • AP-HP Hôpital Paul Brousse, Centre Hépato-Biliaire, 12-14 Avenue Paul Vaillant Couturier, F-94804 Villejuif, France
    • ,
  • D. Azoulay

      Affiliations

    • AP-HP Hôpital Paul Brousse, Centre Hépato-Biliaire, 12-14 Avenue Paul Vaillant Couturier, F-94804 Villejuif, France
    • Corresponding Author InformationCorresponding author. Tel.: +33 145593036; fax: +33 145593857.

,Accepted 22 March 2010.

References 

  1. Ferlay J, Autier P, Boniol M, Heanue M, Colombet M, Boyle P. Estimates of the cancer incidence and mortality in Europe in 2006. Ann Oncol. 2007;18(3):581–592
  2. Garcia M, Jemal A, Ward EM, et al. Global cancer facts and figures 2007. Atlanta, GA: American Cancer Society; 2007;
  3. Stangl R, Altendorf-Hofmann A, Charnley RM, Scheele J. Factors influencing the natural history of colorectal liver metastases. Lancet. 1994;343(8910):1405–1410
  4. Mella J, Biffin A, Radcliffe AG, Stamatakis JD, Steele RJ. Population-based audit of colorectal cancer management in two UK health regions. Colorectal Cancer Working Group, Royal College of Surgeons of England Clinical Epidemiology and Audit Unit. Br J Surg. 1997;84(12):1731–1736
  5. Kune GA, Kune S, Field B, et al. Survival in patients with large-bowel cancer. A population-based investigation from the Melbourne Colorectal Cancer Study. Dis Colon Rectum. 1990;33(11):938–946
  6. Khatri VP, Petrelli NJ, Belghiti J. Extending the frontiers of surgical therapy for hepatic colorectal metastases: is there a limit?. J Clin Oncol. 2005;23:8490–8499
  7. Mann CD, Metcalfe MS, Leopardi LN, Maddern GJ. The clinical risk score: emerging as a reliable preoperative prognostic index in hepatectomy for colorectal metastases. Arch Surg. 2004;139(11):1168–1172
  8. Shaw IM, Rees M, Welsh FK, Bygrave S, John TG. Repeat hepatic resection for recurrent colorectal liver metastases is associated with favourable long-term survival. Br J Surg. 2006;93(4):457–464
  9. Conroy T, Gory-Delabaere G, Adenis A, et al. Clinical practice guideline: 2003 update of Standards, Options and Recommendations for first line palliative chemotherapy in patients with metastatic colorectal cancer (summary report). Bull Cancer. 2004;91(10):759–768
  10. Nordlinger B, Guiguet M, Vaillant JC, et al. Surgical resection of colorectal carcinoma metastases to the liver. A prognostic scoring system to improve case selection, based on 1568 patients. Association Française de Chirurgie. Cancer. 1996;77(7):1254–1262
  11. Fong Y, Fortner J, Sun RL, Brennan MF, Blumgart LH. Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases. Ann Surg. 1999;230(3):309–321
  12. Iwatsuki S, Dvorchik I, Madariaga JR, et al. Hepatic resection for metastatic colorectal adenocarcinoma: a proposal of a prognostic scoring system. J Am Coll Surg. 1999;189(3):291–299
  13. Zakaria S, Donohue JH, Que FG, et al. Hepatic resection for colorectal metastases: value for risk scoring systems?. Ann Surg. 2007;246(2):183–191
  14. Malik HZ, Prasad KR, Halazun KJ, et al. Preoperative prognostic score for predicting survival after hepatic resection for colorectal liver metastases. Ann Surg. 2007;246(5):806–814
  15. Rees M, Tekkis PP, Welsh FK, O'Rourke T, John TG. Evaluation of long-term survival after hepatic resection for metastatic colorectal cancer: a multifactorial model of 929 patients. Ann Surg. 2008;247(1):125–135
  16. Wolpert DH. The relationship between PAC, the statistical physics framework, the Baysesian framework and the VC framework. Technical report of the Santa Fe Institute; 1994;
  17. Breiman L, Friedman JH, Olshen RA, Stone CJ. Classification and Regression trees. Pacific Grove, CA: Wadsworth and Brooks/Cole Advanced Books and Software; 1984;
  18. Kohavi R. A study of cross-validation and bootstrap for accuracy estimation and model selection. International Joint Conference on Artificial Intelligence; 1995.
  19. Miller ME, Hui SL, Tierney WM. Validation techniques for logistic regression models. Stat Med. 1991;10(8):1213–1226
  20. Leitch EF, Chakrabarti M, Crozier JE, et al. Comparison of the prognostic value of selected markers of the systemic inflammatory response in patients with colorectal cancer. Br J Cancer. 2007;97(9):1266–1270
  21. Vogelstain B, Fearon ER, Hamilton SR, et al. Genetic alterations during colorectal tumor development. N Eng J Med. 1988;319:525–532
  22. Ohtani H. Focus on TILs: prognostic significance of tumor infiltrating lymphocytes in human colorectal cancer. Cancer Immun. 2007;7:4
  23. McShane LM, Altman DG, Sauerbrei W, et al. Reporting recommendations for tumor marker prognsotic studies. J Natl Cancer Inst. 2005 Aug;97(16):1180–1184
  24. Zlobec I, Steele R, Terracciano L, Jass JR, Lugli A. Selecting immunohistochemical cut-off scores for novel biomarkers of progression and survival in colorectal cancer. J Clin Pathol. 2007 Oct;60(10):1112–1116
  25. Dimick JB, Cowan JA, Knol JA, Upchurch GR. Hepatic resection in the United States: indications, outcomes, and hospital procedural volumes from a national representative database. Arch Surg. 2003 Feb;138(2):185–191
  26. Bentrem DJ, Brennan MF. Outcomes in o, ncologic surgery: does volume make a difference?. World J Surg. 2005;29:1210–1216
  27. Adam R, Pascal G, Castaing D, et al. Tumor progression while on chemotherapy: a contraindication to liver resection for multiple colorectal metastases?. Ann Surg. 2004;240(6):1052–1056
  28. Azoulay D, Castaing D, Smail A, et al. Resection of nonresecable liver metastases from colorectal cancer after percutaneous portal vein embolization. Ann Surg. 2000;231(4):480–486
  29. Adam R, Laurent A, Azoulay D, Castaing D, Bismuth H. Two-stage hepatectomy: a planed strategy to treat irresecable liver tumors. Ann Surg. 2000 Dec;232(6):777–785
  30. Azoulay D, Eshkenazy R, Andreani P, et al. In situ hypothermic perfusion of the liver versus standard total vascular exclusion for complex liver resection. Ann Surg. 2005;241:277–286

PII: S0748-7983(10)00065-X

doi: 10.1016/j.ejso.2010.03.009

European Journal of Surgical Oncology
Volume 36, Issue 6 , Pages 568-574 , June 2010

Article Tools

* Image Usage & Resolution